Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Post

Showing results (451-460 of 535) with videos related to

Pageof 54
Sort By:
The Lancet. HIV|February 25, 2018
Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trialAlan Winston, Frank A Post, Edwin DeJesus, et al.
The Lancet. HIV|February 28, 2024
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trialGraeme Moyle, Lambert Assoumou, Nathalie de Castro, et al.
HIV Medicine|September 16, 2021
COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in EnglandAlison E Brown, Sara E Croxford, Sophie Nash, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2024
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myelomaPieter Langerhorst, Melissa Baerenfaenger, Purva Kulkarni, et al.
HIV Medicine|January 12, 2024
Clinical epidemiology of COVID-19 in people of black ethnicity living with HIV in the UKZoe Ottaway, Lucy Campbell, Laura R Cechin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 6, 2020
A new health care index predicts short term mortality for TB and HIV co-infected peopleA O Roen, D Podlekareva, R F Miller, et al.
JMIR Public Health and Surveillance|May 2, 2022
Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data EstimatesAlexander L Lundberg, Ramon Lorenzo-Redondo, Judd F Hultquist, et al.
Journal of Graduate Medical Education|January 10, 2014
Update in internal medicine residency education: a review of the literature in 2010 and 2011John E Eaton, Darcy A Reed, Brian M Aboff, et al.
Plos Medicine|October 7, 2020
The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trialH Manisha Yapa, Jan-Walter De Neve, Terusha Chetty, et al.
The Journal of Infection|October 25, 2017
Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV studyA M W Efsen, A Schultze, R F Miller, et al.
Pageof 54

Showing results (451-460 of 535) with videos related to

Sort By:
Pageof 54
The Lancet. HIV|February 25, 2018
Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trialAlan Winston, Frank A Post, Edwin DeJesus, et al.
The Lancet. HIV|February 28, 2024
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trialGraeme Moyle, Lambert Assoumou, Nathalie de Castro, et al.
HIV Medicine|September 16, 2021
COVID-19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID-19 pandemic in EnglandAlison E Brown, Sara E Croxford, Sophie Nash, et al.
Clinical Chemistry and Laboratory Medicine|February 9, 2024
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myelomaPieter Langerhorst, Melissa Baerenfaenger, Purva Kulkarni, et al.
HIV Medicine|January 12, 2024
Clinical epidemiology of COVID-19 in people of black ethnicity living with HIV in the UKZoe Ottaway, Lucy Campbell, Laura R Cechin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 6, 2020
A new health care index predicts short term mortality for TB and HIV co-infected peopleA O Roen, D Podlekareva, R F Miller, et al.
JMIR Public Health and Surveillance|May 2, 2022
Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data EstimatesAlexander L Lundberg, Ramon Lorenzo-Redondo, Judd F Hultquist, et al.
Journal of Graduate Medical Education|January 10, 2014
Update in internal medicine residency education: a review of the literature in 2010 and 2011John E Eaton, Darcy A Reed, Brian M Aboff, et al.
Plos Medicine|October 7, 2020
The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trialH Manisha Yapa, Jan-Walter De Neve, Terusha Chetty, et al.
The Journal of Infection|October 25, 2017
Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV studyA M W Efsen, A Schultze, R F Miller, et al.
Pageof 54